Tom Albright

Tom Albright is the chief executive of Luvantas, a subsidiary of Medytox, which produces Innotox. He has publicly addressed the unauthorized importation of Innotox and emphasized the importance of patient safety, advocating for the administration of botulinum toxins only by qualified healthcare professionals.